# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!


Glucose Transport Defect, Blood-Brain Barrier

Glucose transporter type 1 deficiency syndromeGLUT1 Deficiency Syndrome
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-6 of 6 results.
An Open-Label Trial of Triheptanoin in Patients With Glucose Transporter Type-1 Deficiency Syndrome
Status: Recruiting
Last Changed: Jan 25, 2018
First Received: Jan 15, 2014
Disease(s): Glucose Transporter Type-1 Deficiency Syndrome (Glut1 DS)
Intervention(s): Triheptanoin
Locations: Cook Childrens Medical Center, Fort Worth, Texas, United States
Sodium Lactate Infusion in GLUT1DS Patients
Status: Not yet recruiting
Last Changed: Oct 02, 2019
First Received: Oct 02, 2019
Disease(s): GLUT1 Deficiency Syndrome, GLUT1DS1, GLUT1DS2, Epilepsy, Lactic Acid Blood Increased, Ketogenic Dieting
Intervention(s): sodiumlactate
Locations: Radboudumc, Nijmegen, Gelderland, Netherlands
Expanded Access to Triheptanoin
Status: Available
Last Changed: Aug 27, 2020
First Received: Dec 12, 2018
Disease(s): Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)
Intervention(s): Triheptanoin
Early Diagnosis of the GLUT1 Deficiency Syndrome With a Blood Based Test
Status: Recruiting
Last Changed: Oct 26, 2018
First Received: Oct 26, 2018
Disease(s): Glut1 Deficiency Syndrome, De Vivo Disease, Seizures, Movement Disorders, Intellectual Disability, Ataxia
Intervention(s): METAglut1
Locations: Hôpital Larrey, Angers, France
Hôpital Jean Verdier, Bondy, France
Hôpital Raymond Poincaré, Garche, France
Hôpital Bicêtre, Le Kremlin-Bicêtre, France
Hôpital Gui de Chauliac, Montpellier, France
... and 5 other locations.
The Glucose Transporter Type I Deficiency (G1D) Registry
Status: Recruiting
Last Changed: Jan 18, 2020
First Received: Dec 17, 2013
Disease(s): GLUT1 Deficiency Syndrome, Glucose Transporter Type 1 Deficiency Syndrome, Glucose Transporter type1 (GLUT-1) Deficiency, GLUT-1 Deficiency Syndrome
Intervention(s): No intervention
Locations: UT Southwestern Medical Center, Dallas, Texas, United States
Evaluation of Ketoflo
Status: Recruiting
Last Changed: May 29, 2020
First Received: May 22, 2020
Disease(s): Epilepsy Intractable, Glucose Transporter Type 1 Deficiency Syndrome, Ketogenic Dieting
Intervention(s): Ketoflo
Locations: Bristol Royal Hospital for Children, Bristol, United Kingdom
Leeds Children's Hospital, Leeds, United Kingdom